R. Benjamin Free

1.5k total citations
57 papers, 962 citations indexed

About

R. Benjamin Free is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Computational Theory and Mathematics. According to data from OpenAlex, R. Benjamin Free has authored 57 papers receiving a total of 962 indexed citations (citations by other indexed papers that have themselves been cited), including 55 papers in Molecular Biology, 24 papers in Cellular and Molecular Neuroscience and 9 papers in Computational Theory and Mathematics. Recurrent topics in R. Benjamin Free's work include Receptor Mechanisms and Signaling (50 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Neuropeptides and Animal Physiology (13 papers). R. Benjamin Free is often cited by papers focused on Receptor Mechanisms and Signaling (50 papers), Neurotransmitter Receptor Influence on Behavior (17 papers) and Neuropeptides and Animal Physiology (13 papers). R. Benjamin Free collaborates with scholars based in United States, Australia and United Kingdom. R. Benjamin Free's co-authors include David R. Sibley, Lisa A. Hazelwood, Dennis B. McKay, Amy E. Moritz, Jennie Conroy, Trevor Doyle, Lei Shi, Michele L. Rankin, David Cabrera and David J. Lapinsky and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Chemical Communications.

In The Last Decade

R. Benjamin Free

53 papers receiving 960 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
R. Benjamin Free United States	20	748	426	110	72	64	57	962
Thor S. Thorsen Denmark	12	1.1k 1.5×	734 1.7×	122 1.1×	34 0.5×	42 0.7×	18	1.3k
Neil T. Burford United States	20	870 1.2×	776 1.8×	57 0.5×	38 0.5×	59 0.9×	32	1.1k
Sijie Huang China	13	550 0.7×	304 0.7×	63 0.6×	22 0.3×	58 0.9×	26	738
David L. Roman United States	21	762 1.0×	241 0.6×	75 0.7×	15 0.2×	58 0.9×	55	1.2k
Prashant Donthamsetti United States	19	1.1k 1.4×	852 2.0×	157 1.4×	19 0.3×	80 1.3×	27	1.3k
Viachaslau Bernat Germany	7	780 1.0×	496 1.2×	116 1.1×	31 0.4×	46 0.7×	8	970
Nagaraju Akula United States	10	415 0.6×	224 0.5×	51 0.5×	22 0.3×	62 1.0×	14	1.0k
Dorota Latek Poland	14	675 0.9×	356 0.8×	123 1.1×	14 0.2×	22 0.3×	32	879
Peter Coward United States	17	1.1k 1.4×	427 1.0×	56 0.5×	15 0.2×	73 1.1×	28	1.5k
Vignir Ísberg Denmark	14	1.2k 1.6×	702 1.6×	230 2.1×	26 0.4×	82 1.3×	19	1.4k

Countries citing papers authored by R. Benjamin Free

Since Specialization

Citations

This map shows the geographic impact of R. Benjamin Free's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Benjamin Free with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Benjamin Free more than expected).

Fields of papers citing papers by R. Benjamin Free

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Benjamin Free. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Benjamin Free. The network helps show where R. Benjamin Free may publish in the future.

Co-authorship network of co-authors of R. Benjamin Free

This figure shows the co-authorship network connecting the top 25 collaborators of R. Benjamin Free. A scholar is included among the top collaborators of R. Benjamin Free based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Benjamin Free. R. Benjamin Free is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sánchez‐Soto, Marta, et al.. (2023). GRK2 Enhances ß-arrestin Recruitment to the D2 Dopamine Receptor Through a Mechanism that is Independent From Receptor Phosphorylation or G Protein Activation. Journal of Pharmacology and Experimental Therapeutics. 385. 148–148. 1 indexed citations

Sánchez‐Soto, Marta, Amy E. Moritz, Julia Drube, et al.. (2023). G Protein-Coupled Receptor Kinase 2 Selectively Enhances β-Arrestin Recruitment to the D2 Dopamine Receptor through Mechanisms That Are Independent of Receptor Phosphorylation. Biomolecules. 13(10). 1552–1552. 6 indexed citations

Free, R. Benjamin, Ashley N. Nilson, Trevor Doyle, et al.. (2022). Identification and Characterization of ML321: A Novel and Highly Selective D ₂ Dopamine Receptor Antagonist with Efficacy in Animal Models That Predict Atypical Antipsychotic Activity. ACS Pharmacology & Translational Science. 6(1). 151–170. 1 indexed citations

Aslanoglou, Despoina, Suzanne Bertera, Laura Friggeri, et al.. (2022). Dual pancreatic adrenergic and dopaminergic signaling as a therapeutic target of bromocriptine. iScience. 25(8). 104771–104771. 12 indexed citations

Aslanoglou, Despoina, Suzanne Bertera, Marta Sánchez‐Soto, et al.. (2021). Dopamine regulates pancreatic glucagon and insulin secretion via adrenergic and dopaminergic receptors. Translational Psychiatry. 11(1). 59–59. 68 indexed citations

Free, R. Benjamin, Yoon Namkung, Varun V. Prabhu, et al.. (2021). Pharmacological Characterization of the Imipridone Anticancer Drug ONC201 Reveals a Negative Allosteric Mechanism of Action at the D2 Dopamine Receptor. Molecular Pharmacology. 100(4). 372–387. 22 indexed citations

Moritz, Amy E., Alessandro Bonifazi, Vivek Kumar, et al.. (2020). Evidence for a Stereoselective Mechanism for Bitopic Activity by Extended-Length Antagonists of the D₃ Dopamine Receptor. ACS Chemical Neuroscience. 11(20). 3309–3320. 13 indexed citations

Moritz, Amy E., R. Benjamin Free, Emmanuel Akano, et al.. (2020). Discovery, Optimization, and Characterization of ML417: A Novel and Highly Selective D₃ Dopamine Receptor Agonist. Journal of Medicinal Chemistry. 63(10). 5526–5567. 17 indexed citations

Sánchez‐Soto, Marta, Ravi Kumar Verma, Annah M. Moore, et al.. (2020). A structural basis for how ligand binding site changes can allosterically regulate GPCR signaling and engender functional selectivity. Science Signaling. 13(617). 30 indexed citations

10.

Zeberg, Hugo, Tomasz Maciej Stępniewski, R. Benjamin Free, et al.. (2020). Ligand with Two Modes of Interaction with the Dopamine D₂ Receptor–An Induced-Fit Mechanism of Insurmountable Antagonism. ACS Chemical Neuroscience. 11(19). 3130–3143. 8 indexed citations

11.

Jain, Prashi, R. Benjamin Free, Jennie Conroy, et al.. (2020). Development of pyrimidone D1 dopamine receptor positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 31. 127696–127696. 6 indexed citations

12.

Keck, Thomas M., R. Benjamin Free, Alessandro Bonifazi, et al.. (2019). Dopamine D₄ Receptor-Selective Compounds Reveal Structure–Activity Relationships that Engender Agonist Efficacy. Journal of Medicinal Chemistry. 62(7). 3722–3740. 22 indexed citations

13.

Verma, Ravi Kumar, Ara M. Abramyan, Mayako Michino, et al.. (2018). The E2.65A mutation disrupts dynamic binding poses of SB269652 at the dopamine D2 and D3 receptors. PLoS Computational Biology. 14(1). e1005948–e1005948. 20 indexed citations

14.

Vekariya, Rakesh H., R. Benjamin Free, Yun Li, et al.. (2018). Structure-Activity Investigation of a G Protein-Biased Agonist Reveals Molecular Determinants for Biased Signaling of the D2 Dopamine Receptor. Frontiers in Synaptic Neuroscience. 10. 2–2. 13 indexed citations

15.

Conroy, Jennie, R. Benjamin Free, Noel Southall, et al.. (2018). Identification of Positive Allosteric Modulators of the D1 Dopamine Receptor That Act at Diverse Binding Sites. Molecular Pharmacology. 94(4). 1197–1209. 29 indexed citations

16.

Moritz, Amy E., R. Benjamin Free, & David R. Sibley. (2017). Advances and challenges in the search for D2 and D3 dopamine receptor-selective compounds. Cellular Signalling. 41. 75–81. 44 indexed citations

17.

Furman, Cheryse A., Rebecca A. Roof, Amy E. Moritz, et al.. (2014). Investigation of the binding and functional properties of extended length D3 dopamine receptor-selective antagonists. European Neuropsychopharmacology. 25(9). 1448–1461. 21 indexed citations

18.

Free, R. Benjamin, Sara M. Thomasy, David J. Lapinsky, et al.. (2002). Structure–activity studies with ring E analogues of methyllycaconitine on bovine adrenal α3β4* nicotinic receptors. Neuroscience Research. 42(1). 57–63. 40 indexed citations

19.

Free, R. Benjamin & Dennis B. McKay. (2001). Receptor protection studies to characterize neuronal nicotinic receptors: tubocurarine prevents alkylation of adrenal nicotinic receptors. Brain Research. 891(1-2). 176–184. 15 indexed citations

20.

Bergmeier, Stephen C., David J. Lapinsky, R. Benjamin Free, & Dennis B. McKay. (1999). Ring E analogs of methyllycaconitine (MLA) as novel nicotinic antagonists. Bioorganic & Medicinal Chemistry Letters. 9(15). 2263–2266. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact